P-wave amplitude and pulmonary artery pressure in scleroderma

Journal of Electrocardiology

Volumn 39, Issue 4, 2006, Pages 385-388

  Wokhlu, Nina ^a   Hsu, Vivien M ^a   Wilson, Alan ^a   Moreyra, Abel E ^a   Shindler, Daniel ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Electrocardiogram; P wave amplitude; Scleroderma

Indexed keywords

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MALE; MICROVASCULATURE; P WAVE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SCLERODERMA; SENSITIVITY AND SENSIBILITY; TIME SERIES ANALYSIS;

ADULT; AGED; BLOOD PRESSURE; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 33748980962     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2006.01.004     Document Type: Article

References (18)

1. Rolla G., Colagrande P., Scappaticci E., et al. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension. J Rheumatol 27 (2000) 1693
2. Stupi A., Steen V.D., Owens G.R., Barnes E.L., Rodnan G.P., and Medsger Jr. T.A. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 4 (1986) 515
3. McLaughlin V.V., Presber K.W., Doyle R.L., et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 1 Suppl (2004) 78
4. Sandoval J., Bauerle O., Palomar A., et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89 (1994) 1733
5. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 (1991) 343
6. Targa L., Cardin G., Cozzi F., Glorioso S., Rossi L., and Todesco S. Electrocardiographic disorders in diverse clinical variations of scleroderma. G Clin Med 71 (1990) 17 [Italian]
7. Morelli S., Sgreccia A., Ferrante L., et al. Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol 57 (1996) 151
8. Edmundoptics.com [homepage on the Internet] Barrington, NJ: Edmund Optics, Inc. c2005. Available from: http://www.edmundoptics.com/.
9. Prineas R.J., Crow R.S., and Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Standards and Procedures for Measurement and Classification (1982), John Wright PSG Inc, Boston
10. American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 (1980) 581
11. SAS Procedures Guide, Version 8. Cary (NC): SAS Institute, Inc.; 1999. p. 1643.
12. Bossone E., Paciocco G., Iarussi D., et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 121 (2002) 513
13. Asad N., Johnson V.M., and Spodick D. Acute right atrial strain: regression in normal as well as abnormal P-wave amplitudes with treatment of obstructive pulmonary disease. Chest 124 (2003) 560
14. Galie N., Torbicki A., Barst R., et al. ESC Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J 25 (2004) 2243
15. Hsu V.M., Shinnar M., Moreyra A., et al. Assessment of pulmonary hypertension (PH) in systemic sclerosis(SSc): a comparison of Doppler echocardiography, cardiac MRI, and right heart catheterization. Arthritis Rheum 50 (2004) S424 [Abstract #1059]
16. Dixen U., Joens C., Rasmussen B.V., Parner J., and Jensen G.B. Signal-averaged P wave duration and the dimensions of the atria. Ann Noninvasive Electrocardiol 9 (2004) 309
17. Jobsis M.M., Crow J.W., and Long W. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39 (2002) 1214
18. Gaine S.P., and Rubin L.J. Primary pulmonary hypertension. Lancet 352 (1998) 719